{"transactions":[{"id":732530,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:06:18.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":37037,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":78076,"source":{"system":"sec-edgar","filing":"0001193125-26-275819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526275819/ownership.xml","form_type":"4"}},{"id":857013,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-06T21:20:26.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":2363,"price":12.5508,"value":29657.5404,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 69,552 previously reported restricted stock units."}],"balance_after":88746,"source":{"system":"sec-edgar","filing":"0001193125-26-096594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526096594/ownership.xml","form_type":"4"}},{"id":857012,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-06T21:20:26.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":2425,"price":12.9163,"value":31322.0275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 69,552 previously reported restricted stock units."}],"balance_after":91109,"source":{"system":"sec-edgar","filing":"0001193125-26-096594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526096594/ownership.xml","form_type":"4"}},{"id":859691,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T23:50:59.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":84261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date."}],"balance_after":84261,"derivative":{"exercise_price":13.03,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":84261},"source":{"system":"sec-edgar","filing":"0001193125-26-094472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526094472/ownership.xml","form_type":"4"}},{"id":859690,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-03-05T23:50:59.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":35495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 45,590 previously reported restricted stock units."}],"balance_after":93534,"source":{"system":"sec-edgar","filing":"0001193125-26-094472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526094472/ownership.xml","form_type":"4"}},{"id":934708,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-01-21T21:09:29.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":4873,"price":14.38,"value":70073.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 45,590 previously reported restricted stock units."}],"balance_after":58039,"source":{"system":"sec-edgar","filing":"0001193125-26-017960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526017960/ownership.xml","form_type":"4"}},{"id":1123362,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T01:34:40.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":10752,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":41039,"source":{"system":"sec-edgar","filing":"0000950170-25-081956","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025081956/ownership.xml","form_type":"4"}},{"id":1224455,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T21:16:42.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":82070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date."}],"balance_after":82070,"derivative":{"exercise_price":16.98,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":82070},"source":{"system":"sec-edgar","filing":"0000950170-25-033602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025033602/ownership.xml","form_type":"4"}},{"id":1224454,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-03-05T21:16:42.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":34600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,979 previously reported restricted stock units."}],"balance_after":62912,"source":{"system":"sec-edgar","filing":"0000950170-25-033602","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025033602/ownership.xml","form_type":"4"}},{"id":1299210,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-21T21:18:16.000Z","date":"2025-01-16","kind":"sale","planned":false,"acquired":false,"shares":4655,"price":17.89,"value":83277.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,979 previously reported restricted stock units."}],"balance_after":28312,"source":{"system":"sec-edgar","filing":"0000950170-25-007228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025007228/ownership.xml","form_type":"4"}},{"id":1477723,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T22:45:28.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":3685,"price":58.5291,"value":215679.7335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 3,685 shares sold in the price range of $58.32 to $59.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30287,"source":{"system":"sec-edgar","filing":"0000950170-24-074473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024074473/ownership.xml","form_type":"4"}},{"id":1477722,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T22:45:28.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":11940,"price":57.8399,"value":690608.406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2024 by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 11,940 shares sold in the price range of $57.32 to $58.29 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33972,"source":{"system":"sec-edgar","filing":"0000950170-24-074473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024074473/ownership.xml","form_type":"4"}},{"id":1485365,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:05:40.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":2554,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":45912,"source":{"system":"sec-edgar","filing":"0000950170-24-071281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017024071281/ownership.xml","form_type":"4"}},{"id":1678472,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-18T00:22:22.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":76878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date."}],"balance_after":76878,"derivative":{"exercise_price":13.65,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":76878},"source":{"system":"sec-edgar","filing":"0001209191-24-001811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919124001811/doc4.xml","form_type":"4"}},{"id":1678471,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-01-18T00:22:22.000Z","date":"2024-01-15","kind":"grant","planned":false,"acquired":true,"shares":32967,"price":13.65,"value":449999.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."}],"balance_after":32967,"source":{"system":"sec-edgar","filing":"0001209191-24-001811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919124001811/doc4.xml","form_type":"4"}},{"id":1867700,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T20:27:26.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":5731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":43358,"source":{"system":"sec-edgar","filing":"0001209191-23-034296","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919123034296/doc4.xml","form_type":"4"}},{"id":2245522,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-04T00:19:37.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":8624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant.  \"Date of Grant\" shall mean June 2, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":37627,"source":{"system":"sec-edgar","filing":"0001209191-22-034386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000120919122034386/doc4.xml","form_type":"4"}},{"id":2613320,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:18:17.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":15625,"price":16,"value":250000.0,"ownership":{"direct":true},"balance_after":29003,"source":{"system":"sec-edgar","filing":"0000899243-21-031812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031812/doc4.xml","form_type":"4"}},{"id":2613319,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:18:17.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":7645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of August 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":13378,"source":{"system":"sec-edgar","filing":"0000899243-21-031812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031812/doc4.xml","form_type":"4"}},{"id":2613318,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T23:18:17.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":5733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following August 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":5733,"source":{"system":"sec-edgar","filing":"0000899243-21-031812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000089924321031812/doc4.xml","form_type":"4"}},{"id":2981244,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":11618,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":19.36,"expiration_date":"2022-05-18","underlying":"Ordinary Shares","underlying_shares":11618},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981243,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":13816,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":23.93,"expiration_date":"2023-05-14","underlying":"Ordinary Shares","underlying_shares":13816},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981242,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":8546,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":29.06,"expiration_date":"2024-05-13","underlying":"Ordinary Shares","underlying_shares":8546},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981241,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":14293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":14293},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981240,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":14293,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":14293},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981239,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":15720,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":21.24,"expiration_date":"2026-07-19","underlying":"Ordinary Shares","underlying_shares":15720},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981238,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":10622,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":10622},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981237,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":10651,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":10651},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981236,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":12152,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":12152},"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981235,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":15842,"price":30.75,"value":487141.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981234,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":15842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":15842,"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981233,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":6801,"price":30.75,"value":209130.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"See Exhibit 99.1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981232,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":11455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration.  See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 5,849 Shares issuable upon vesting of the Wright RSUs and 952 Shares issuable upon vesting of the 2020 RSUs.  See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":6801,"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":2981231,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T18:04:42.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":31782,"price":30.75,"value":977296.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2019, Wright Medical Group N.V. (the \"Issuer\") entered into a purchase agreement (the \"Purchase Agreement\") with Stryker Corporation and its subsidiary, Stryker B.V. (the \"Purchaser\").  Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (\"Shares\"), of the Issuer (the \"Offer\"), and, on November 11, 2020 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 31,782 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,849 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, \"Wright RSUs\") and 12,407 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the \"2020 RSUs\").  See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":18256,"source":{"system":"sec-edgar","filing":"0001790300-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000007/primary_doc.xml","form_type":"4"}},{"id":3052328,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-08-19T16:10:59.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":1083,"price":30.1765,"value":32681.1495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.17 to $30.18, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,885 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 15,371 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":50038,"source":{"system":"sec-edgar","filing":"0001235802-20-000101","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000101/primary_doc.xml","form_type":"4"}},{"id":3075559,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-27T16:01:08.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":12407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.  The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 16,358 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":51121,"source":{"system":"sec-edgar","filing":"0001235802-20-000080","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000080/primary_doc.xml","form_type":"4"}},{"id":3095189,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-01T18:18:36.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":2691,"price":29.533,"value":79473.303,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of performance share unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.5308 to $29.535, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":38714,"source":{"system":"sec-edgar","filing":"0001686266-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000004/primary_doc.xml","form_type":"4"}},{"id":3095188,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-01T18:18:36.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":7196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the payout of a performance share unit award for the June 26, 2017 to June 28, 2020 performance period under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, as approved by the Issuer's Compensation Committee of its Board of Directors.  Performance share unit awards are paid in ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":41405,"source":{"system":"sec-edgar","filing":"0001686266-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000004/primary_doc.xml","form_type":"4"}},{"id":3122031,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-06-04T16:08:58.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":505,"price":29.6811,"value":14988.9555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.6701 to $29.6850, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":34209,"source":{"system":"sec-edgar","filing":"0001235802-20-000056","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000056/primary_doc.xml","form_type":"4"}},{"id":3332474,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-23T16:16:00.000Z","date":"2019-12-20","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option has fully vested."}],"balance_after":11618,"derivative":{"exercise_price":19.36,"expiration_date":"2022-05-18","underlying":"Ordinary Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001235802-19-000141","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000141/primary_doc.xml","form_type":"4"}},{"id":3332473,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-12-23T16:16:00.000Z","date":"2019-12-20","kind":"sale","acquired":false,"shares":7001,"price":30.0974,"value":210711.8974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.08 to $30.125, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":34714,"source":{"system":"sec-edgar","filing":"0001235802-19-000141","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000141/primary_doc.xml","form_type":"4"}},{"id":3332472,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Global Finance"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-12-23T16:16:00.000Z","date":"2019-12-20","kind":"exercise","acquired":true,"shares":9000,"price":19.36,"value":174240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":41715,"source":{"system":"sec-edgar","filing":"0001235802-19-000141","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000141/primary_doc.xml","form_type":"4"}},{"id":3433252,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance, CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-08-20T16:08:54.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":712,"price":21.0301,"value":14973.4312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":32715,"source":{"system":"sec-edgar","filing":"0001235802-19-000109","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000109/primary_doc.xml","form_type":"4"}},{"id":3453242,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance, CAO"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T16:06:08.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":12152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":12152,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":12152},"source":{"system":"sec-edgar","filing":"0001235802-19-000074","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000074/primary_doc.xml","form_type":"4"}},{"id":3453241,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance, CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-07-30T16:06:08.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":3951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 6,669 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":33427,"source":{"system":"sec-edgar","filing":"0001235802-19-000074","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000074/primary_doc.xml","form_type":"4"}},{"id":3500498,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-06-05T16:11:45.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":1447,"price":30.647,"value":44346.209,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.62 to $30.65, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 6,669 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":29476,"source":{"system":"sec-edgar","filing":"0001235802-19-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000047/primary_doc.xml","form_type":"4"}},{"id":3838290,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance and CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-08-20T16:15:21.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":348,"price":27.1441,"value":9446.1468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,205 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 6,669 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":30923,"source":{"system":"sec-edgar","filing":"0001235802-18-000126","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000126/primary_doc.xml","form_type":"4"}},{"id":3860831,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & CAO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T16:06:36.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":10651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":10651,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":10651},"source":{"system":"sec-edgar","filing":"0001235802-18-000099","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000099/primary_doc.xml","form_type":"4"}},{"id":3860830,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance & CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T16:06:36.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":3970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,205 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 7,568 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":31271,"source":{"system":"sec-edgar","filing":"0001235802-18-000099","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000099/primary_doc.xml","form_type":"4"}},{"id":3903419,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Finance & CAO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-06-06T16:01:35.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":1466,"price":24.62,"value":36092.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $24.48 to $24.84, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,205 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 3,598 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":27301,"source":{"system":"sec-edgar","filing":"0001235802-18-000070","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000070/primary_doc.xml","form_type":"4"}},{"id":4251016,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T18:01:48.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":10622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":10622,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":10622},"source":{"system":"sec-edgar","filing":"0001235802-17-000125","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000125/primary_doc.xml","form_type":"4"}},{"id":4251015,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Accounting Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-07-26T18:01:48.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":3598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,043 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 3,598 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":28767,"source":{"system":"sec-edgar","filing":"0001235802-17-000125","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000125/primary_doc.xml","form_type":"4"}},{"id":4291069,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36914,"kind":"person","name":"Andrews Julie","position":1,"cik":"0001550508","reported_name":"Andrews Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Accounting Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-06-06T16:12:53.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":1480,"price":27.11,"value":40122.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.98 to $27.22, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,043 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan."}],"balance_after":25169,"source":{"system":"sec-edgar","filing":"0001235802-17-000062","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000062/primary_doc.xml","form_type":"4"}}]}